EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

STING in cancer immunoediting: Modeling tumor-immune dynamics throughout cancer development

Xiao Zhang, Yan Chen, Xi Liu, Guoli Li, Shuo Zhang, Qi Zhang, Zihan Cui, Minglu Qin, Hans-Uwe Simon, Janoš Terzić, Gordana Kocic, Bojan Polić und 5 weitere

Cancer Letters · 2025-03 · 612 · 217410

DOI: 10.1016/j.canlet.2024.217410 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Letters, 2025-03. Verfasst von Xiao Zhang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbi…. Hauptthemen laut MEDLINE: Neoplasms, Membrane Proteins. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 373 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Ministry of Education of the People's Republic of China, Harbin Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer immunoediting is a dynamic process of tumor-immune system interaction that plays a critical role in cancer development and progression. Recent studies have highlighted the importance of innate signaling pathways possessed by both cancer cells and immune cells in this process. The STING molecule, a pivotal innate immune signaling molecule, mediates DNA-triggered immune responses in both cancer cells and immune cells, modulating the anti-tumor immune response and shaping the efficacy of immunotherapy. Emerging evidence has shown that the activation of STING signaling has dual opposing effects in cancer progression, simultaneously provoking and restricting anti-tumor immunity, and participating in every phase of cancer immunoediting, including immune elimination, equilibrium, and escape. In this review, we elucidate the roles of STING in the process of cancer immunoediting and discuss the dichotomous effects of STING agonists in the cancer immunotherapy response or resistance. A profound understanding of the sophisticated roles of STING signaling pathway in cancer immunoediting would potentially inspire the development of novel cancer therapeutic approaches and overcome the undesirable protumor effects of STING activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsMembrane ProteinsHumansSignal TransductionImmunotherapyAnimalsImmunity, InnateTumor MicroenvironmentTumor EscapeSTING Protein

Stichwörter der Autor:innen

Cancer immunoeditingCancer immunotherapySTINGSTING agonists

Substanzen

Membrane ProteinsSTING1 protein, humanSTING Protein

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin 150001, People's Republic of China; Department of Pathology, Harbin…
  • Department of Pathology, Harbin Medical University, Harbin, 150081, People's Republic of China.
  • Department of Cardiology, ordos central hospital, Ordos, People's Republic of China.
  • Department of Colorectal and Anal Surgery, Chifeng Municipal Hospital, Chifeng Clinical Medical School of Inner Mongolia Medical University, Chifeng, People's Republic of China.
  • Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin 150001, People's Republic of China.
  • Institute of Pharmacology, University of Bern, 3010 Bern, Switzerland; Institute of Biochemistry, Brandenburg Medical School, Neuruppin, 16816, Germany.

Förderung

  • National Natural Science Foundation of China
  • Ministry of Education of the People's Republic of China
  • Harbin Medical University
  • Natural Science Foundation of Heilongjiang Province

Zitieren

APA

Zhang, X., Chen, Y., Liu, X., Li, G., Zhang, S., Zhang, Q., Cui, Z., Qin, M., Simon, H. U., Terzić, J., Kocic, G., Polić, B., Yin, C., Li, X., Zheng, T., Liu, B., & Zhu, Y. (2025). STING in cancer immunoediting: Modeling tumor-immune dynamics throughout cancer development. Cancer Letters, 612, 217410. https://doi.org/10.1016/j.canlet.2024.217410

Vancouver

Zhang X, Chen Y, Liu X, Li G, Zhang S, Zhang Q, et al. STING in cancer immunoediting: Modeling tumor-immune dynamics throughout cancer development. Cancer Letters. 2025;612:217410. doi:10.1016/j.canlet.2024.217410

BibTeX
@article{Zhang2025,
  author = {Zhang, Xiao and Chen, Yan and Liu, Xi and Li, Guoli and Zhang, Shuo and Zhang, Qi and Cui, Zihan and Qin, Minglu and Simon, Hans-Uwe and Terzić, Janoš and Kocic, Gordana and Polić, Bojan and Yin, Chengliang and Li, Xiaobo and Zheng, Tongsen and Liu, Bing and Zhu, Yuanyuan},
  title = {STING in cancer immunoediting: Modeling tumor-immune dynamics throughout cancer development},
  journal = {Cancer Letters},
  year = {2025},
  volume = {612},
  pages = {217410},
  doi = {10.1016/j.canlet.2024.217410}
}
Kostenlos starten →